Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Ipragliflozin. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Ipragliflozin. |
| Moxifloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Methyclothiazide. |
| Chlorthalidone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Chlorthalidone. |
| Bendroflumethiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Bendroflumethiazide. |
| Metolazone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Metolazone. |
| Benzthiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Benzthiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Hydroflumethiazide. |
| Indapamide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Indapamide. |
| Chlorothiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Polythiazide. |
| Quinethazone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Quinethazone. |
| Cyclopenthiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Cyclopenthiazide. |
| Epitizide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Epitizide. |
| Amitriptyline | Amitriptyline may decrease the hypoglycemic activities of Ipragliflozin. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Ipragliflozin. |
| Imipramine | Imipramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Nortriptyline | Nortriptyline may decrease the hypoglycemic activities of Ipragliflozin. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Ipragliflozin. |
| Trimipramine | Trimipramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Doxepin | Doxepin may decrease the hypoglycemic activities of Ipragliflozin. |
| Desipramine | Desipramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Clomipramine | Clomipramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Ipragliflozin. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Ipragliflozin. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Ipragliflozin. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Ipragliflozin. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Ipragliflozin. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Ipragliflozin. |
| Opipramol | Opipramol may decrease the hypoglycemic activities of Ipragliflozin. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the hypoglycemic activities of Ipragliflozin. |
| Dibenzepin | Dibenzepin may decrease the hypoglycemic activities of Ipragliflozin. |
| Quinupramine | Quinupramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Melitracen | Melitracen may decrease the hypoglycemic activities of Ipragliflozin. |
| Lofepramine | Lofepramine may decrease the hypoglycemic activities of Ipragliflozin. |
| Iprindole | Iprindole may decrease the hypoglycemic activities of Ipragliflozin. |
| Imipramine oxide | Imipramine oxide may decrease the hypoglycemic activities of Ipragliflozin. |
| Dapagliflozin | Dapagliflozin may increase the hypoglycemic activities of Ipragliflozin. |
| Canagliflozin | Canagliflozin may increase the hypoglycemic activities of Ipragliflozin. |
| Leuprolide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Leuprolide. |
| Goserelin | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Goserelin. |
| Torasemide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Torasemide. |
| Nelfinavir | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Nelfinavir. |
| Indinavir | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Indinavir. |
| Ziprasidone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Ziprasidone. |
| Etonogestrel | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Etonogestrel. |
| Desogestrel | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Desogestrel. |
| Olanzapine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Olanzapine. |
| Megestrol acetate | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Megestrol acetate. |
| Clozapine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Clozapine. |
| Levonorgestrel | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Levonorgestrel. |
| Progesterone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Progesterone. |
| Chlorpromazine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Chlorpromazine. |
| Haloperidol | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Haloperidol. |
| Ritonavir | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Ritonavir. |
| Piperazine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Piperazine. |
| Medroxyprogesterone acetate | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Medroxyprogesterone acetate. |
| Cyclothiazide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Cyclothiazide. |
| Niacin | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Niacin. |
| Epinephrine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Epinephrine. |
| Furosemide | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Furosemide. |
| Norethisterone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Norethisterone. |
| Risperidone | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Risperidone. |
| Pentamidine | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Pentamidine. |
| Ethynodiol diacetate | The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Ethynodiol diacetate. |